Literature DB >> 19687022

Cardiac neurotransmission imaging with 123I-meta-iodobenzylguanidine in postural tachycardia syndrome.

Carl-Albrecht Haensch1, Hartmut Lerch, Hans Schlemmer, Anna Jigalin, Stefan Isenmann.   

Abstract

BACKGROUND: Postural orthostatic tachycardia syndrome (POTS) is a disorder of orthostatic intolerance characterised by excessive tachycardia of unknown aetiology. Whether this condition involves abnormal cardiac sympathetic innervation or function remains elusive. Meta-iodobenzylguanidine (MIBG) resembles guanethidine and is a pharmacologically inactive analogue of norepinephrine, which is similarly metabolised in noradrenergic neurons. MIBG myocardial scintigraphy is used clinically to estimate local myocardial sympathetic nerve damage in some forms of heart disease and autonomic neuropathy. The objective of this study was to evaluate cardiac sympathetic innervation in patients with POTS.
METHODS: 20 patients with POTS were studied using (123)I-MIBG-single photon emission computed tomography, standardised autonomic testing, assessment of catecholamine plasma levels and sympathetic skin response.
RESULTS: In four POTS patients (20.0%), myocardial MIBG uptake was markedly decreased. The mean heart to mediastinum ratio was reduced to 1.22+/-0.08 compared with the normal range of >1.7. No correlation was found between myocardial MIBG uptake and degree of postural tachycardia, baroreflex sensitivity, catecholamine plasma levels or other autonomic parameters. Sympathetic skin responses were normal in all patients.
CONCLUSIONS: These findings suggest that POTS may be, in part, a manifestation of autonomic cardiac neuropathy. MIBG myocardial scintigraphy may be helpful to distinguish patients with neuropathic POTS from patients with orthostatic intolerance of other origin.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19687022     DOI: 10.1136/jnnp.2008.168484

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  8 in total

Review 1.  Postural tachycardia syndrome--current experience and concepts.

Authors:  Christopher J Mathias; David A Low; Valeria Iodice; Andrew P Owens; Mojca Kirbis; Rodney Grahame
Journal:  Nat Rev Neurol       Date:  2011-12-06       Impact factor: 42.937

2.  Beyond postural tachycardia syndrome.

Authors:  Hossam I Mustafa; David Robertson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-03       Impact factor: 10.154

3.  New onset postural orthostatic tachycardia syndrome following ablation of AV node reentrant tachycardia.

Authors:  Khalil Kanjwal; Beverly Karabin; Mujeeb Sheikh; Yousuf Kanjwal; Blair P Grubb
Journal:  J Interv Card Electrophysiol       Date:  2010-08-14       Impact factor: 1.900

4.  Gastric emptying in postural tachycardia syndrome: a preliminary report.

Authors:  Ki-Jong Park; Wolfgang Singer; David M Sletten; Phillip A Low; Adil E Bharucha
Journal:  Clin Auton Res       Date:  2013-05-25       Impact factor: 4.435

Review 5.  Postural tachycardia syndrome: a heterogeneous and multifactorial disorder.

Authors:  Eduardo E Benarroch
Journal:  Mayo Clin Proc       Date:  2012-11-01       Impact factor: 7.616

Review 6.  Sympathetic dysfunction in vasovagal syncope and the postural orthostatic tachycardia syndrome.

Authors:  Elisabeth Lambert; Gavin W Lambert
Journal:  Front Physiol       Date:  2014-07-28       Impact factor: 4.566

7.  Sleep disturbances and autonomic dysfunction in patients with postural orthostatic tachycardia syndrome.

Authors:  Julia Mallien; Stefan Isenmann; Anne Mrazek; Carl-Albrecht Haensch
Journal:  Front Neurol       Date:  2014-07-07       Impact factor: 4.003

Review 8.  Postural tachycardia syndrome: current perspectives.

Authors:  Rachel Wells; Andrew J Spurrier; Dominik Linz; Celine Gallagher; Rajiv Mahajan; Prashanthan Sanders; Amanda Page; Dennis H Lau
Journal:  Vasc Health Risk Manag       Date:  2017-12-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.